5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
India
Ovarian Cancer Diagnostics and Therapeutics Market - Growth, Trends, and Forecast (2020 - 2025)
This report is segmented by Type Cancer (Epithelial Ovarian Tumors, Ovarian Germ Cell Tumors, and Others), Modality, and Geography.
- ABOUT THIS REPORT
- Market Snapshot
- Market Overview
- Scope of the Report
- Key Market Trends
- Competitive Landscape
- Major Players
- TABLE OF CONTENTS
Market Snapshot
Study Period:
2016-2024
Base Year:
2019
Fastest Growing Market:
Asia Pacific
Largest Market:
North America
Major Players:
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
Market Overview
Ovarian cancer is the fifth most common cause of cancer deaths in women, globally, and the tenth most common cancer among women in the United States. The incidences of ovarian cancer are high in women aged 55-64 years. The major symptoms of ovarian cancer include bloating, pelvic and abdominal pain, difficulty in eating, and urinary symptoms. According to the US Census Bureau, women above 60 years of age account for almost 57% of all ovarian cancer incidences and 75% of all ovarian cancer related deaths worldwide, with a median age at diagnosis being 63 years and the median age at death being 70 years. Thus, the increasing geriatric population is driving the growth of the ovarian cancer diagnostics and therapeutics market. An accurate diagnosis for ovarian cancer is critical, as in most cases, cancer already begins to spread to the lymph nodes and outside of the pelvis at the time of diagnosis. Ovariancancerawareness.org reports that the five-year survival rate for ovarian cancer with early stage 1 detection is 93% and that most new cases of ovarian cancer are diagnosed at stage 3 or later, leaving little time as well as room for an accurate diagnosis
Scope of the Report
Ovarian cancer is a type of cancer that begins in the ovaries. There are several types of ovarian cancer, Epithelial ovarian cancer is the most common type of ovarian cancer. The report covers four major types of ovarian cancer namely epithelial ovarian tumors, ovarian germ cell tumors, and others. As per the scope of the report, other ovarian cancer types are covered in these four segments. For example, epithelial ovarian tumors cover cancer types such as primary peritoneal cancer and fallopian tube cancer which are similar to epithelial ovarian cancer and are treated and diagnosed in similar ways.
| By Cancer Type | |
| Epithelial Ovarian Tumors | |
| Ovarian Germ Cell Tumors | |
| Others |
| By Modality | ||||||||
| ||||||||
|
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Report scope can be customized per your requirements. Click here.
Key Market Trends
CT Scan Segment is Expected to Register Robust Growth
Computed Tomography (CT) is an imaging procedure that uses special X-ray equipment to create detailed pictures, or scans, of areas inside the body. It is also called computerized tomography and computerized axial tomography (CAT). These equipment do not show small ovarian tumors well, but they can see larger tumors, and may be able to see if the tumor is growing into nearby structures. It can also find the enlarged lymph nodes, signs of cancer spread to liver or other organs, or signs that an ovarian tumor is affecting the kidneys or bladder.
To understand key trends, Download Sample Report
United States is Expected to Retain Largest Market Share During the Period of Forecast.
Among the North American region, the United States holds the highest share in the ovarian cancer diagnostics and therapeutics market and has contributed majorly for the same. Ovarian cancer is the ninth most common cancer and the fifth leading cause of cancer death among women in the United States. A woman’s lifetime risk of developing ovarian cancer is about one in 73 in the country. Most of the top global ovarian cancer diagnostics players are headquartered in the United States and this tends to be the major advantage for the region. High prevalence in the region and the rising incidence of an aging population are the factors that drive the market.
To understand geography trends, Download Sample Report.
Competitive Landscape
Key players in the market include AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb Company, Eli Lilly and Company, F. Hoffman-La Roche Ltd, GlaxoSmithKline Plc, Johnson and Johnson, Kazia Therapeutics, and Siemens Healthineers among others.
Table Of Contents
1. INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidences of Ovarian Cancer Worldwide
4.2.2 Use of Combination Therapies for the Treatment of Ovarian Cancer
4.2.3 Rising Geriatric Population
4.3 Market Restraints
4.3.1 Lack of Accurate Diagnosis of Ovarian Cancer
4.3.2 Lack of Awareness in Emerging and Low Income Economies
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Cancer Type
5.1.1 Epithelial Ovarian Tumors
5.1.2 Ovarian Germ Cell Tumors
5.1.3 Others
5.2 By Modality
5.2.1 Diagnosis
5.2.1.1 Biopsy
5.2.1.2 Blood Tests
5.2.1.3 Ultrasound
5.2.1.4 PET
5.2.1.5 CT Scan
5.2.1.6 Other Diagnoses
5.2.2 Therapeutics
5.2.2.1 Chemotherapy
5.2.2.2 Radiation Therapy
5.2.2.3 Immunotherapy
5.2.2.4 Hormonal Therapy
5.2.2.5 Others
5.3 Geography
5.3.1 North America
5.3.1.1 US
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 UK
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Astrazeneca
6.1.2 Boehringer Ingelheim
6.1.3 Bristol Myers Squibb Company
6.1.4 Eli Lilly and Company
6.1.5 F. Hoffman-La Roche Ltd
6.1.6 Glaxosmithkline Plc
6.1.7 Johnson and Johnson
6.1.8 Kazia Therapeutics Ltd
6.1.9 Siemens Healthineers
*List Not Exhaustive7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
LINKS
JOIN US
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination.
Interested? Please email us
[email protected]© 2020. All Rights Reserved to Mordor Intelligence.